vigabatrin

Product NDC
0591-3955
11-digit product format
005913955
Labeler code
0591
Product ID
0591-3955_bb26e312-15c4-4764-ae8b-b309c3d8d362
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
vigabatrin
Dosage form
POWDER, FOR SOLUTION
Route
ORAL
Labeler
Actavis Pharma, Inc.
Application
ANDA209824
Marketing category
ANDA
Marketing start
2020-05-14
Marketing end
0000-00-00
Substance
VIGABATRIN
Active strength
50 mg/mL
Pharmacologic classes
Anti-epileptic Agent [EPC]
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

Additional Listing Data#

Finished product
No
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
VIGABATRIN50 mg/mL

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0591-3955-11EA - Each0591-3955076a9339-32ec-4751-b0cb-c4c7ee27431012020-06-05
0591-3955-50EA - Each0591-3955139ea3b2-44db-4017-8be5-6d67e067785212020-06-05

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
0591-3955VIGABATRIN POWDER, FOR SOLUTION [ACTAVIS PHARMA, INC.]8Legacy NDC20230615_1ce1c52d-441a-4ed7-afff-568192197454.zip

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
0591-3955-500059139555050 PACKET in 1 CARTON (0591-3955-50) > 10 mL in 1 PACKET (0591-3955-11) 50 packet2020-05-140000-00-00NoNoCurrent